What's new

Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of authorisation: 28/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of authorisation: 28/02/2025, Status: Authorised

May 8, 2025 - 16:06
 0
Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of authorisation: 28/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of authorisation: 28/02/2025, Status: Authorised
Read More

Tags:

Previous Article

IHCL Expands Portfolio with New Ginger Hotel in Bengaluru

Next Article

PepsiCo taps Amazon Web Services to accelerate digital transformation, AI adoption

Related Posts

Human medicines European public assessment report (EPAR): Circadin, melatonin, Date of authorisation: 29/06/2007, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

May 5, 2025  0

Human medicines European public assessment report (EPAR): Eptifibatide Accord, eptifibatide, Date of authorisation: 11/01/2016, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

May 2, 2025  0

Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 22, 2025  0